Clinical IntelligenceAsk Reedley
Ask the record. See the source.
Ask a question about one patient; Reedley searches the records available to it and answers line by line, each line linked to its source, for you to judge.
Interactive demonstration
Synthetic patient · pause, step and replay at any point
Six questions about one synthetic patient. Each answer is built only from the entries supplied to this demonstration, and every line links to its source. Reedley does not give treatment advice.
Daniel OKONKWO NHS 999 000 0115
Born 02 Nov 1961 · 65 y · male · Record as of 12 Nov 2026 09:40
Six questions about one synthetic patient. Each answer is built only from the entries supplied to this demonstration, and every line links to its source. Reedley does not give treatment advice.
Step 1 of 5 · The record, as supplied · Continues as you scroll
Why amlodipine stopped
- The record, as supplied
- Question asked
- Structured search
- Consultation text by meaning Illustrative
- Findings with sources
- Conflicting entries Illustrative
- Not found, and what was read
- Follow-up keeps context Illustrative
Why was this patient’s amlodipine stopped?
62 entries supplied for this synthetic patient
- Consultations8: read for this question, 2 cited in the answer.
- Letter paragraphs (3 letters)11: read for this question, 2 cited in the answer.
- Results7: not needed for this question.
- Medication history8: read for this question, 2 cited in the answer.
- Current medication record5: not needed for this question.
- Referrals2: not needed for this question.
- Problems4: not needed for this question.
- Allergies and intolerances1: read for this question.
- Reedley work history16: not needed for this question.
Counts are the entries supplied to this demonstration. Reedley cannot see anything that was not supplied.
- Medication historyFound · 2 sources
- Consultations (free text, by meaning)Found · 2 sources
- Letter paragraphsFound · 2 sources
- Allergies and intolerancesNot found in the available record
One answer, each line linked to the entries it rests on
The record documents that amlodipine was stopped on 17 Jun 2026 because of ankle oedema, and lercanidipine 10 mg once daily was started the same day.
- Record factThe medication record shows amlodipine stopped on 17 Jun 2026, with the reason recorded as ankle oedema.E1Medication record · 17 Jun 2026
- Record factIllustrativeThe consultation that day (Dr S. PATEL) records six weeks of ankle swelling and the switch.E2Consultation · 17 Jun 2026 · Dr S. PATEL
- Derived by ReedleyIllustrativeReedley’s reconstruction from dated entries: the dose was increased from 5 mg to 10 mg on 22 Apr 2026, eight weeks before the stop. The link between the increase and the swelling comes from the consultation entry, not from Reedley.E3Medication record · 22 Apr 2026
- Record factIllustrativeA nurse consultation on 15 Jul 2026 records that the ankle swelling had gone after the stop.E4Consultation · 15 Jul 2026 · Practice nurse
- Conflicting entries · later correspondence addresses itIllustrativeThe renal clinic letter dated 5 Oct 2026 asks for an amlodipine increase; the medication record shows amlodipine stopped on 17 Jun 2026. A reply from the renal team, dated 20 Oct and received 23 Oct, refers to lercanidipine instead.Renal clinic letter5 Oct 2026
Please increase amlodipine to 10 mg once daily
E5Renal clinic letter ¶2 · dated 5 Oct 2026Medication record17 Jun 2026Amlodipine stopped.
E1Medication record · 17 Jun 2026Later correspondence addresses itMy letter of 5 October was written from an out-of-date medication list
E6Renal clinic reply ¶1 · dated 20 Oct 2026 - Not found in the available recordNo allergy or intolerance entry for amlodipine.Searched: Allergies and intolerances (1 entry: codeine)
Uncertainty Built only from the 62 entries supplied for this synthetic patient, as of 12 Nov 2026 09:40. Consultation free text was searched by meaning, which is illustrative. Reedley does not judge whether stopping was the right decision.
Open the contextOpen the 17 Jun 2026 consultationOpen the medication historyOpen the renal correspondence
What was searched · 4 sources, 28 entries read, 6 cited
- Medication historyFound · 2 sources
- Consultations (free text, by meaning)Found · 2 sources
- Letter paragraphsFound · 2 sources
- Allergies and intolerancesNot found in the available record
Which parts are in the development build
- Structured search of the medication history and letters
- Each finding linked to its entry and quoted span
- “Not found in the available record”, with what was searched
- Search of consultation free text by meaning
- The reconstruction line
- The conflict summary with the later reply
- The follow-up question that keeps context
Record references
6 entries behind this answer · newest first · as of 12 Nov 2026 09:40
Dr A. FENWICK · Northfield General Hospital (fictional)
Thank you for your query of 6 October. My letter of 5 October was written from an out-of-date medication list and should have referred to lercanidipine. Please continue lercanidipine 10 mg once daily; I am not asking for any change to it.
Dr A. FENWICK · Northfield General Hospital (fictional)
Please increase amlodipine to 10 mg once daily and recheck blood pressure in 4 weeks.
Practice nurse
BP check. Ankle swelling resolved since stopping amlodipine. BP 134/82. Continue lercanidipine.
Dr S. PATEL
Ankle swelling both legs for 6 weeks since amlodipine increased to 10 mg in April. No breathlessness. Mild pitting oedema to mid-shin. BP 138/84. Amlodipine stopped because of ankle oedema; switched to lercanidipine 10 mg OD. Review in 4 weeks.
Dr S. PATEL
Amlodipine stopped. Reason recorded: ankle oedema.
Dr S. PATEL
Amlodipine increased from 5 mg to 10 mg once daily.
Context kept: “the swelling” = ankle oedema, from the previous answer · “since” = after 17 Jun 2026
Has the swelling come back since?
Context kept: “the swelling” = ankle oedema, from the previous answer · “since” = after 17 Jun 2026
- Record fact15 Jul 2026: the practice nurse records that the swelling had gone.E4Consultation · 15 Jul 2026 · Practice nurse
- Not found in the available recordNo later entry mentions ankle swelling or oedema.Searched: Consultations after 15 Jul 2026 (2) and letter paragraphs after 15 Jul 2026 (11)
Recent medication changes
- The record, as supplied
- Question asked
- Structured search
- Findings with sources
- Conflicting entries Illustrative
- Follow-up keeps context Illustrative
What changed in this patient’s medication recently?
62 entries supplied for this synthetic patient
- Consultations8: not needed for this question.
- Letter paragraphs (3 letters)11: read for this question, 3 cited in the answer.
- Results7: not needed for this question.
- Medication history8: read for this question, 5 cited in the answer.
- Current medication record5: read for this question, 1 cited in the answer.
- Referrals2: not needed for this question.
- Problems4: not needed for this question.
- Allergies and intolerances1: not needed for this question.
- Reedley work history16: not needed for this question.
Counts are the entries supplied to this demonstration. Reedley cannot see anything that was not supplied.
- Medication historyFound · 5 sources
- Current medication recordFound · 1 source
- Letter paragraphsFound · 3 sources
One answer, each line linked to the entries it rests on
Three changes on the medication record in the last 6 months: amlodipine stopped and lercanidipine started on 17 Jun 2026, and dapagliflozin started on 7 Oct 2026.
- Record fact17 Jun 2026 · amlodipine stopped; reason recorded: ankle oedema.E1Medication record · 17 Jun 2026
- Record fact17 Jun 2026 · lercanidipine 10 mg once daily started; indication: hypertension.E2Medication record · 17 Jun 2026
- Record fact7 Oct 2026 · dapagliflozin 10 mg once daily started, as asked in the renal clinic letter dated 5 Oct.E3Medication record · 7 Oct 2026E4Renal clinic letter ¶3 · dated 5 Oct 2026
- Derived by ReedleyReedley’s reconstruction of the current list: lercanidipine, ramipril, atorvastatin and dapagliflozin. Ramipril has no recorded change since 8 Feb 2021 and atorvastatin none since it started on 12 Mar 2019.E5medication record · as at 12 Nov 2026E6Medication record · 8 Feb 2021E7Medication record · 12 Mar 2019
- Conflicting entries · later correspondence addresses itIllustrativeThe renal clinic letter dated 5 Oct 2026 asks for an amlodipine increase; the medication record shows amlodipine stopped on 17 Jun 2026. A reply from the renal team, dated 20 Oct and received 23 Oct, refers to lercanidipine instead.Renal clinic letter5 Oct 2026
Please increase amlodipine to 10 mg once daily
E8Renal clinic letter ¶2 · dated 5 Oct 2026Medication record17 Jun 2026Amlodipine stopped.
E1Medication record · 17 Jun 2026Later correspondence addresses itMy letter of 5 October was written from an out-of-date medication list
E9Renal clinic reply ¶1 · dated 20 Oct 2026
Uncertainty Covers changes recorded on the practice medication record and requests in the letters supplied. A change made elsewhere and not yet written to the record would not appear here.
Open the contextOpen the medication historyOpen the renal clinic letter
What was searched · 3 sources, 24 entries read, 9 cited
- Medication historyFound · 5 sources
- Current medication recordFound · 1 source
- Letter paragraphsFound · 3 sources
Which parts are in the development build
- Structured search of medication history and the current record
- Letter paragraphs cited with their source
- The conflict summary with the later reply
- The follow-up question that keeps context
Record references
11 entries behind this answer · newest first · as of 12 Nov 2026 09:40
Medication record · as at 12 Nov 2026
Ramipril 10mg capsules 10 mg once daily · indication: hypertension · last issued 2 Nov 2026
Medication record · as at 12 Nov 2026
Dapagliflozin 10mg tablets 10 mg once daily · no indication recorded · last issued 2 Nov 2026
Dr A. FENWICK · Northfield General Hospital (fictional)
Thank you for your query of 6 October. My letter of 5 October was written from an out-of-date medication list and should have referred to lercanidipine. Please continue lercanidipine 10 mg once daily; I am not asking for any change to it.
K. AHMED
Telephone: renal clinic letter of 5 Oct discussed. Dapagliflozin 10 mg once daily started as requested in the letter; sick-day guidance explained. Amlodipine instruction queried with the renal team because he no longer takes amlodipine.
K. AHMED
Dapagliflozin 10 mg once daily started. No indication text entered.
Dr A. FENWICK · Northfield General Hospital (fictional)
Please increase amlodipine to 10 mg once daily and recheck blood pressure in 4 weeks.
Dr A. FENWICK · Northfield General Hospital (fictional)
His urine albumin:creatinine ratio remains raised. I would be grateful if you could start dapagliflozin 10 mg once daily for his chronic kidney disease and check his urea and electrolytes 4 to 6 weeks after starting.
Dr S. PATEL
Amlodipine stopped. Reason recorded: ankle oedema.
Dr S. PATEL
Lercanidipine 10 mg once daily started. Indication: hypertension.
Ramipril increased from 5 mg to 10 mg once daily.
Atorvastatin 20 mg at night started. Indication: hypercholesterolaemia.
Context kept: “the dapagliflozin” = started 7 Oct 2026, from the previous answer
Who asked for the dapagliflozin?
Context kept: “the dapagliflozin” = started 7 Oct 2026, from the previous answer
- Record factThe renal clinic letter dated 5 Oct 2026 (Dr A. FENWICK) asks the practice to start it.E4Renal clinic letter ¶3 · dated 5 Oct 2026
- Record factK. AHMED records starting it by telephone on 7 Oct 2026.E10Consultation · 7 Oct 2026 · K. AHMED
- Not found in the available recordNo indication text on the medication record entry for dapagliflozin.Searched: Current medication record (5 entries) and the 7 Oct 2026 medication eventE11medication record · as at 12 Nov 2026
Draft monitoring rules
- The record, as supplied
- Question asked
- Structured search
- Consultation text by meaning Illustrative
- Findings with sources
- Not found, and what was read
- Follow-up keeps context Illustrative
Which of his medicines have a draft monitoring rule?
62 entries supplied for this synthetic patient
- Consultations8: not needed for this question.
- Letter paragraphs (3 letters)11: read for this question, 1 cited in the answer.
- Results7: read for this question, 1 cited in the answer.
- Medication history8: not needed for this question.
- Current medication record5: read for this question, 4 cited in the answer.
- Referrals2: not needed for this question.
- Problems4: not needed for this question.
- Allergies and intolerances1: not needed for this question.
- Reedley work history16: not needed for this question.
Counts are the entries supplied to this demonstration. Reedley cannot see anything that was not supplied.
- Practice monitoring rules (draft · unsigned)Found · 3 sources
- Current medication recordFound · 4 sources
- ResultsFound · 1 source
- Letter paragraphsFound · 1 source
One answer, each line linked to the entries it rests on
Under the practice’s draft monitoring rules, two of his four current medicines have a monitoring requirement: ramipril and dapagliflozin. Both point to the same test, U&E.
- Derived by ReedleyIllustrativeRamipril · draft rule: U&E at least every 12 months. Latest U&E received 9 Nov 2026, so the next is due by 9 Nov 2027 under this rule.E1medication record · as at 12 Nov 2026E2Practice monitoring rule · draft · unsignedE3Result · received 9 Nov 2026 15:20
- Derived by ReedleyIllustrativeDapagliflozin · draft rule: U&E at least every 12 months, and an earlier test asked for in specialist correspondence is followed as written. The renal letter asked for U&E 4 to 6 weeks after starting; started 7 Oct, U&E received 9 Nov (33 days).
Dapagliflozin 10mg tablets 10 mg once daily
an earlier test requested in specialist correspondence is followed as written
check his urea and electrolytes 4 to 6 weeks after starting
Dapagliflozin 10 mg once daily started.
E4medication record · as at 12 Nov 2026E5Practice monitoring rule · draft · unsignedE6Renal clinic letter ¶3 · dated 5 Oct 2026E7Medication record · 7 Oct 2026 - Derived by ReedleyIllustrativeAtorvastatin · the draft rule covers the first 12 months after starting. It started on 12 Mar 2019, so the rule sets no current requirement.E8medication record · as at 12 Nov 2026E9Practice monitoring rule · draft · unsignedE10Medication record · 12 Mar 2019
- Not found in the available recordIllustrativeLercanidipine is not named in any of the practice’s draft monitoring rules.Searched: Practice monitoring rule table (16 draft rules)E11medication record · as at 12 Nov 2026
Uncertainty The draft rules do not yet take account of kidney function category, age or indication; a clinician sets each patient’s interval. Answered only from the practice’s own draft rule table, which has no named clinical owner yet and is not clinical guidance. Monitoring a specialist asks for in a future letter is added when that letter arrives.
Open the contextOpen the draft rule tableOpen the 9 Nov 2026 result
What was searched · 4 sources, 39 entries read, 11 cited
- Practice monitoring rules (draft · unsigned)Found · 3 sources
- Current medication recordFound · 4 sources
- ResultsFound · 1 source
- Letter paragraphsFound · 1 source
Which parts are in the development build
- Versioned draft rule table read against the medication record
- Each requirement linked to its rule and the latest result
- The follow-up question that keeps context
Record references
12 entries behind this answer · newest first · as of 12 Nov 2026 09:40
U&E at least every 12 months while on an ACE inhibitor or angiotensin receptor blocker.
U&E at least every 12 months while on dapagliflozin; an earlier test requested in specialist correspondence is followed as written.
ALT within 3 months and at 12 months after starting a statin.
Medication record · as at 12 Nov 2026
Lercanidipine 10mg tablets 10 mg once daily · indication: hypertension · last issued 2 Nov 2026
Medication record · as at 12 Nov 2026
Ramipril 10mg capsules 10 mg once daily · indication: hypertension · last issued 2 Nov 2026
Medication record · as at 12 Nov 2026
Atorvastatin 20mg tablets 20 mg at night · indication: hypercholesterolaemia · last issued 2 Nov 2026
Medication record · as at 12 Nov 2026
Dapagliflozin 10mg tablets 10 mg once daily · no indication recorded · last issued 2 Nov 2026
Northfield Pathology (fictional) · received 9 Nov 2026 15:20
U&E: Na 140 mmol/L, K 4.6 mmol/L, creatinine 131 µmol/L, eGFR 52 mL/min/1.73m² · no laboratory flag
K. AHMED
Dapagliflozin 10 mg once daily started. No indication text entered.
Dr A. FENWICK · Northfield General Hospital (fictional)
His urine albumin:creatinine ratio remains raised. I would be grateful if you could start dapagliflozin 10 mg once daily for his chronic kidney disease and check his urea and electrolytes 4 to 6 weeks after starting.
Dr A. FENWICK · Northfield General Hospital (fictional)
I will review him in the renal clinic in 6 months.
Atorvastatin 20 mg at night started. Indication: hypercholesterolaemia.
Context kept: “the next one” = the next monitoring test for ramipril and dapagliflozin, from the previous answer
When is the next one due?
Context kept: “the next one” = the next monitoring test for ramipril and dapagliflozin, from the previous answer
- Derived by ReedleyUnder the draft rules only: both give the same date, U&E by 9 Nov 2027, 12 months after the 9 Nov 2026 result.E3Result · received 9 Nov 2026 15:20
- Record factThe renal clinic letter also plans a clinic review in 6 months.E12Renal clinic letter ¶4 · dated 5 Oct 2026
The cardiology letter
- The record, as supplied
- Question asked
- Structured search
- Consultation text by meaning Illustrative
- Findings with sources
- Not found, and what was read
- Follow-up keeps context Illustrative
What did the cardiologist recommend?
62 entries supplied for this synthetic patient
- Consultations8: read for this question, 1 cited in the answer.
- Letter paragraphs (3 letters)11: read for this question, 3 cited in the answer.
- Results7: not needed for this question.
- Medication history8: read for this question, 2 cited in the answer.
- Current medication record5: not needed for this question.
- Referrals2: read for this question.
- Problems4: not needed for this question.
- Allergies and intolerances1: not needed for this question.
- Reedley work history16: not needed for this question.
Counts are the entries supplied to this demonstration. Reedley cannot see anything that was not supplied.
- Letter paragraphsFound · 3 sources
- ReferralsNot found in the available record
- Consultations (free text, by meaning)Found · 1 source
- Medication historyFound · 2 sources
One answer, each line linked to the entries it rests on
As documented in the cardiology clinic letter dated 2 Sep 2026 (Dr J. MORLEY): continue the current antihypertensive treatment, with a clinic blood pressure target below 140/90 mmHg, and one conditional suggestion about bisoprolol.
- Record factParagraph 3, as written:
I would recommend continuing his current antihypertensive treatment, aiming for a clinic blood pressure below 140/90 mmHg.
E1Cardiology clinic letter ¶3 · dated 2 Sep 2026 - Record factParagraph 4, as written. Conditional wording: shown to a clinician as a decision, never turned into a medication task.
If the palpitations become troublesome, please consider bisoprolol 1.25 mg once daily.
E2Cardiology clinic letter ¶4 · dated 2 Sep 2026 - Record factParagraph 5: no further cardiology follow-up was arranged.E3Cardiology clinic letter ¶5 · dated 2 Sep 2026
- Record factIllustrativeA telephone consultation on 4 Sep 2026 (Dr S. PATEL) records the discussion of the letter.E4Consultation · 4 Sep 2026 · Dr S. PATEL
- Derived by ReedleyIllustrativeReedley’s reconstruction: on 2 Sep 2026 the medication record showed lercanidipine 10 mg and ramipril 10 mg once daily as his antihypertensive medicines.E5Medication record · 17 Jun 2026E6Medication record · 8 Feb 2021
- Not found in the available recordNo later cardiology correspondence.Searched: Letters (3 letters, 11 paragraphs) and referrals (2)
Uncertainty Shows what the letter says, word for word. Reedley does not weigh the cardiologist’s advice against other entries or suggest what to do with it.
Open the contextOpen the cardiology letterOpen the 4 Sep 2026 consultation
What was searched · 4 sources, 29 entries read, 6 cited
- Letter paragraphsFound · 3 sources
- ReferralsNot found in the available record
- Consultations (free text, by meaning)Found · 1 source
- Medication historyFound · 2 sources
Which parts are in the development build
- Exact search of letters
- Paragraphs quoted with their source
- Conditional wording routed to a clinician
- Consultation free text found by meaning
- The reconstruction line
- The follow-up question that keeps context
Record references
7 entries behind this answer · newest first · as of 12 Nov 2026 09:40
Dr S. PATEL
Telephone: cardiology letter discussed. Palpitations now infrequent. Prefers not to start a new medicine at present; will contact the practice if they become troublesome.
Dr J. MORLEY · Northfield General Hospital (fictional)
I would recommend continuing his current antihypertensive treatment, aiming for a clinic blood pressure below 140/90 mmHg.
Dr J. MORLEY · Northfield General Hospital (fictional)
If the palpitations become troublesome, please consider bisoprolol 1.25 mg once daily.
Dr J. MORLEY · Northfield General Hospital (fictional)
I have not arranged further cardiology follow-up and have discharged him to the care of his GP.
Northfield General Hospital (fictional)
Referral to cardiology outpatients (routine): intermittent palpitations.
Dr S. PATEL
Lercanidipine 10 mg once daily started. Indication: hypertension.
Ramipril increased from 5 mg to 10 mg once daily.
Context kept: “the bisoprolol” = bisoprolol 1.25 mg once daily in the cardiology letter, paragraph 4
Did he start the bisoprolol?
Context kept: “the bisoprolol” = bisoprolol 1.25 mg once daily in the cardiology letter, paragraph 4
- Record fact4 Sep 2026: the telephone consultation records his preference.E4Consultation · 4 Sep 2026 · Dr S. PATEL
- Not found in the available recordNo bisoprolol prescription or medication event.Searched: Medication history (8) and the current medication record (5)
Latest renal function
- The record, as supplied
- Question asked
- Structured search
- Findings with sources
- Follow-up keeps context Illustrative
When was the latest renal function result recorded?
62 entries supplied for this synthetic patient
- Consultations8: not needed for this question.
- Letter paragraphs (3 letters)11: not needed for this question.
- Results7: read for this question, 3 cited in the answer.
- Medication history8: not needed for this question.
- Current medication record5: not needed for this question.
- Referrals2: not needed for this question.
- Problems4: not needed for this question.
- Allergies and intolerances1: not needed for this question.
- Reedley work history16: read for this question, 1 cited in the answer.
Counts are the entries supplied to this demonstration. Reedley cannot see anything that was not supplied.
- ResultsFound · 3 sources
- Reedley work historyFound · 1 source
One answer, each line linked to the entries it rests on
The latest U&E was received in the record on 9 Nov 2026 at 15:20 (sample taken 9 Nov 08:50). As reported: creatinine 131 µmol/L, eGFR 52 mL/min/1.73m², no laboratory flag.
- Record factShown as the laboratory reported it (Northfield Pathology, fictional).E1Result · received 9 Nov 2026 15:20
- Record factA clinician’s review of this result is recorded.E2Reedley work history · 12 Nov 2026 08:31
- Record factEarlier U&E results, listed as reported for context: 3 Jun 2026 and 14 Nov 2025.E3Result · received 3 Jun 2026 15:48E4Result · received 14 Nov 2025 16:05
Uncertainty Shows when results arrived in the record and what the laboratory reported. Reedley does not interpret results or the change between them.
Open the contextOpen the 9 Nov 2026 resultOpen the result’s work history
What was searched · 2 sources, 23 entries read, 4 cited
- ResultsFound · 3 sources
- Reedley work historyFound · 1 source
Which parts are in the development build
- Structured search of results
- Values shown as reported, with the received time
- Linked work history
- The follow-up question that keeps context
Record references
5 entries behind this answer · newest first · as of 12 Nov 2026 09:40
08:31 · Reedley, from the clinical record (Simulated)
Reviewed and filed by K. AHMED 12 Nov 2026 08:31. U&E item closed · completed.
15:20 · Reedley (Simulated)
U&E received in the record: the test happened; designed to stay open until a clinician’s review of this result is recorded (the development build closes on receipt).
Northfield Pathology (fictional) · received 9 Nov 2026 15:20
U&E: Na 140 mmol/L, K 4.6 mmol/L, creatinine 131 µmol/L, eGFR 52 mL/min/1.73m² · no laboratory flag
Northfield Pathology (fictional) · received 3 Jun 2026 15:48
U&E: Na 140 mmol/L, K 4.7 mmol/L, creatinine 124 µmol/L, eGFR 56 mL/min/1.73m² · no laboratory flag
Northfield Pathology (fictional) · received 14 Nov 2025 16:05
U&E: Na 141 mmol/L, K 4.5 mmol/L, creatinine 119 µmol/L, eGFR 59 mL/min/1.73m² · no laboratory flag
Context kept: “renal function” = U&E · “before that” = before 9 Nov 2026
And the one before that?
Context kept: “renal function” = U&E · “before that” = before 9 Nov 2026
- Record fact3 Jun 2026 · received 15:48, as reported.E3Result · received 3 Jun 2026 15:48
Outstanding work
- The record, as supplied
- Question asked
- Structured search
- Findings with sources
- Not found, and what was read
- Follow-up keeps context Illustrative
Which clinical tasks remain outstanding?
62 entries supplied for this synthetic patient
- Consultations8: not needed for this question.
- Letter paragraphs (3 letters)11: read for this question, 1 cited in the answer.
- Results7: not needed for this question.
- Medication history8: not needed for this question.
- Current medication record5: not needed for this question.
- Referrals2: not needed for this question.
- Problems4: not needed for this question.
- Allergies and intolerances1: not needed for this question.
- Reedley work history16: read for this question, 4 cited in the answer.
Counts are the entries supplied to this demonstration. Reedley cannot see anything that was not supplied.
- Reedley work historyFound · 4 sources
- Letter paragraphsFound · 1 source
One answer, each line linked to the entries it rests on
Two open work items as of 12 Nov 2026 09:40: the structured medication review, assigned to K. AHMED for today at 10:30, and the blood pressure recheck, booked for 16 Nov with attendance not yet confirmed.
- Record factStructured medication review · assigned · owner K. AHMED · appointment 12 Nov 10:30.E1Reedley work history · 2 Nov 2026 08:15
- Record factBlood pressure recheck · actioned · booked by the patient for 16 Nov 09:20. Booked is not attended.E2Reedley work history · 29 Oct 2026 14:06E3Renal clinic reply ¶2 · dated 20 Oct 2026
- Derived by ReedleyClosed in the last 30 days, for context: the amlodipine clarification (26 Oct, after the renal reply was reviewed) and the U&E after starting dapagliflozin (12 Nov 08:31).E4Reedley work history · 26 Oct 2026 09:30E5Reedley work history · 12 Nov 2026 08:31
- Not found in the available recordTasks kept only in the clinical system’s own task list.Searched: Not supplied to this demonstration, so not searched
Uncertainty Lists Reedley work items and their lifecycle states. Actioned means reported, not proven: the recheck stays open until a blood pressure reading is recorded.
Open the contextOpen My Day for this patient →Open the medication review →
What was searched · 2 sources, 27 entries read, 5 cited
- Reedley work historyFound · 4 sources
- Letter paragraphsFound · 1 source
Which parts are in the development build
- Work items with owner, due date and lifecycle state
- Event history for each item
- The follow-up question that keeps context
Record references
7 entries behind this answer · newest first · as of 12 Nov 2026 09:40
08:31 · Reedley, from the clinical record (Simulated)
Reviewed and filed by K. AHMED 12 Nov 2026 08:31. U&E item closed · completed.
08:15 · K. AHMED
Assigned: structured medication review · owner K. AHMED · appointment 12 Nov 10:30 (medication review date on the repeat template: 14 Nov 2026).
14:06 · Reedley (Simulated)
Booked by the patient for 16 Nov 09:20 · attendance not yet confirmed.
09:30 · Admin team
Actioned: invitation sent by text (delivered, not read).
09:32 · K. AHMED
Assigned: blood pressure recheck · owner Practice nurse · due 17 Nov (4 weeks from the reply dated 20 Oct).
09:30 · K. AHMED
Reviewed by K. AHMED: renal reply dated 20 Oct. Amlodipine clarification closed · completed. Blood pressure recheck identified (reply ¶2).
Dr A. FENWICK · Northfield General Hospital (fictional)
I would still be grateful if his blood pressure could be rechecked in 4 weeks, as planned.
Context kept: “the blood pressure check” = the open recheck item, from the previous answer
Who is doing the blood pressure check?
Context kept: “the blood pressure check” = the open recheck item, from the previous answer
- Record factOwner: Practice nurse, assigned 26 Oct 09:32, due 17 Nov.E6Reedley work history · 26 Oct 2026 09:32
- Record factInvitation sent by text 27 Oct: delivered, not read. Booked by the patient 29 Oct.E7Reedley work history · 27 Oct 2026 09:30E2Reedley work history · 29 Oct 2026 14:06
In the development build · synthetic data, except steps marked Illustrative · Scripted reconstruction: the development build itself is not running on this page.
- Every line of an answer links to the document, result or entry behind it.
- Coverage is stated in words: what was searched and from which date.
- When the records cannot support an answer, Reedley says so plainly.
From what arrives to what you decide
- What entersA question about one patient
- What Reedley preparesAn answer line by line, each line linked to its source
- What the clinician decidesYou judge the answer against the sources
What it does not do · what exists today
- Ask Reedley gives no treatment advice.
- Absence of evidence is not proof of absence: the answer says what was searched.
- In the development build, questions are read by a deterministic planner, no language model is consulted and consultation free text is not searched.
- Answers come only from the synthetic records supplied to the demonstration.
Every patient shown is synthetic. No integration with a clinical system is claimed, and no clinician has yet used Reedley in practice. Safety and governance
See it with your own work in mind.
Tell us your role and the workflows you care about, and we will walk you through them on synthetic data.